Stockreport

Oxford Biomedica notes Axovant’s positive six-month follow-up from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report
PDF Oxford Biomedica notes Axovant’s positive six-month follow-up from second cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD           Oxford, UK – 6 October, 2020: Oxf [Read more]